Ambit Biosciences Overview

Life ScienceCompany

Was Ambit Biosciences formerly PE-backed?

Yes. Ambit Biosciences was formerly owned by 1 private investor.

Where is Ambit Biosciences headquartered?

Ambit Biosciences is headquartered in San Diego, California.

What sector is Ambit Biosciences in?

Ambit Biosciences is a life science company.

Ambit Biosciences Corp.

4215 Sorrento Valley Boulevard,
San Diego, California 92121
United States,
(858) 334-2100
www.ambitbio.com

Ambit Biosciences Corp. is a biotechnology company focused on oncology; provides drug discovery services to the pharmaceutical industry.



Try Mergr Free — See This and 220,573+
Other Company and Investor Profiles Today

Try free. Full access. Cancel anytime.

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.8K Private Equity Firms
  • 214K M&A Transactions
  • 216K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 83K M&A Contacts
    (PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.